Susan E Graf
CIK 1577637 · Chief Business Officer · last filed 2026-06-05
Susan E Graf is a Chief Business Officer who has filed 15 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for CGON, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$306.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
15
-$306.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CGON | Director | — | $59.56 | — | $0 | 3 | 2026-06-05 |
| AARD | Director | — | $3.90 | — | $0 | 1 | 2025-06-13 |
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Director | 5,010 | $7.30 | $36.6K | $1.4K | 3 | 2023-06-09 |
| Epizyme, Inc. (EPZM) Delisted | Chief Business Officer | — | $1.47 | — | $0 | 3 | 2018-02-13 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | VP,Corp Development & Strategy | 0 | — | — | -$307.8K | 5 | 2015-02-24 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | CGON | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | AARD | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | CGON | Grant (A) | — | $0 | EDGAR |
| 2024-10-07 | CGON | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Mixed | +5,010 | $1.4K | EDGAR |
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-27 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-09 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-26 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |